2018
DOI: 10.1099/jmm.0.000776
|View full text |Cite
|
Sign up to set email alerts
|

High diversity in SCCmec elements among multidrug-resistant Staphylococcus haemolyticus strains originating from paediatric patients; characterization of a new composite island

Abstract: A high diversity of SCCmec elements with the prevalence of a new composite island was determined among MRSH strains. The structure of the composite island represented by MDR-SH strains in this study, in combination with the presence of a restriction-modification system type III, is described for the first time in this study. The presence of an 8 bp direct repeat (DR) and the sequences flanking the DR may support the integration of the mecA gene complex as a composite transposon (IS431-mecA-IS431) independently… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
9
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 35 publications
2
9
0
Order By: Relevance
“…This result is consistent with a previous study indicating that MRSH is prevalently detected in inpatients accounting for 83.6% (Ternes et al 2013). Moreover, MRSH has been identified as the dominant player in catheter-linked bacteremia in the intensive care unit patients (Rodríguez-Aranda et al 2009) including neonatal and pediatric patients (Hosseinkhani et al 2018;Ternes et al 2013). Furthermore, other studies also revealed the high survival and adaptive potential of MRSH strains within healthcare environment as they are detected and cross-transmission not only through medical devices (Kim et al 2012), but also patients and hospital staff (Squeri et al 2012).…”
Section: Discussionsupporting
confidence: 92%
“…This result is consistent with a previous study indicating that MRSH is prevalently detected in inpatients accounting for 83.6% (Ternes et al 2013). Moreover, MRSH has been identified as the dominant player in catheter-linked bacteremia in the intensive care unit patients (Rodríguez-Aranda et al 2009) including neonatal and pediatric patients (Hosseinkhani et al 2018;Ternes et al 2013). Furthermore, other studies also revealed the high survival and adaptive potential of MRSH strains within healthcare environment as they are detected and cross-transmission not only through medical devices (Kim et al 2012), but also patients and hospital staff (Squeri et al 2012).…”
Section: Discussionsupporting
confidence: 92%
“…Currently, vancomycin, linezolid and rifampicin are the treatment of choice for Staphylococcus haemolyticus infections 14, 21 , our results showed that resistance to vancomycin and linezolid do not exist, particularly with the absence of vanA gene (0% in this study) which in agreement with what reported worldwide, however, resistance to rifampicin exhibited by 30% of the isolates reported in this study is alarming, emerging Staphylococcus haemolyticus resistant to rifampicin have been reported 7 , Resistance to glycopeptides (vancomycin and teicoplanin) remains rarely detected in Staphylococcus haemolyticus 3, 6, 14, 16, 18 . Despite the total absence of vancomycin/teicoplanin, linezolid resistant isolates and the apparently low prevalence of rifampicin resistance among Staphylococcus haemolyticus reported in this study, wide surveillance of susceptibility patterns of these drugs among Staphylococcus haemolyticus of clinical origin is mandatory, since the development of resistance to these drugs may exist at low levels 17 .…”
Section: Resultssupporting
confidence: 89%
“…Some Staphylococcus strains are considered inhabitants of the normal microbiota, and do not have all the virulence factors found in S. aureus. Their emerging threat comes from the fact that these bacteria can carry a large number of antimicrobial resistance genes [15], [16]. Due to the increase in antibiotic resistance in the recent years as a result of the use of these antibiotics, the World Health Organization announced a "global action plan on antimicrobial resistance" [17].…”
Section: Resultsmentioning
confidence: 99%